Global markets have shown resilience recently, with small-cap stocks outperforming their larger counterparts and technology shares rebounding amid optimism for growth potential. In the context of this evolving market landscape, understanding what makes a good investment is crucial. While the term “penny stock” may seem outdated, it still refers to smaller or less-established companies that can offer substantial value when they possess robust financials and a clear path to growth.
Name
Share Price
Market Cap
Financial Health Rating
Lever Style (SEHK:1346)
HK$1.51
HK$946.34M
★★★★★★
Foresight Group Holdings (LSE:FSG)
£4.095
£467M
★★★★★★
IVE Group (ASX:IGL)
A$2.89
A$439.55M
★★★★★☆
TK Group (Holdings) (SEHK:2283)
HK$2.43
HK$2.02B
★★★★★★
Angler Gaming (NGM:ANGL)
SEK3.60
SEK269.95M
★★★★★★
Angler Gaming (DB:0QM)
€0.37
€228.7M
★★★★★★
CNMC Goldmine Holdings (Catalist:5TP)
SGD1.06
SGD429.61M
★★★★★☆
Yangzijiang Shipbuilding (Holdings) (SGX:BS6)
SGD3.37
SGD13.26B
★★★★★☆
Integrated Diagnostics Holdings (LSE:IDHC)
$0.67
$389.49M
★★★★★☆
RGB International Bhd (KLSE:RGB)
MYR0.21
MYR323.58M
★★★★★★
Click here to see the full list of 3,574 stocks from our Global Penny Stocks screener.
Let’s take a closer look at a couple of our picks from the screened companies.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: CM Energy Tech Co., Ltd. is an investment holding company involved in the design, manufacture, installation, and commissioning of land and offshore drilling rigs and equipment globally, with a market cap of HK$908.16 million.
Operations: CM Energy Tech generates its revenue from three main segments: Equipment manufacturing and packages ($98.59 million), Supply chain and integration services ($25.25 million), and Assets management and engineering services ($54.63 million).
Market Cap: HK$908.16M
CM Energy Tech Co., Ltd. is navigating the penny stock landscape with a diversified revenue stream across equipment manufacturing, supply chain services, and asset management. Despite recent negative earnings growth and low return on equity at 3.9%, the company remains debt-free with stable weekly volatility of 6%. Its short-term assets significantly cover both short- and long-term liabilities, suggesting financial resilience. A new agreement with China Merchants Industry Holdings for vessel chartering could bolster future operations, pending shareholder approval. However, its board’s inexperience may pose challenges in strategic execution as it continues to trade below estimated fair value.
SEHK:206 Debt to Equity History and Analysis as at Dec 2025
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Boustead Singapore Limited is an investment holding company offering energy engineering, real estate, geospatial, and healthcare technology solutions across various regions including Singapore, Australia, and the United States with a market cap of SGD858.03 million.
Operations: The company’s revenue is primarily derived from its Geospatial segment at SGD231.68 million, followed by Energy Engineering at SGD158.40 million, Real Estate Solutions at SGD124.97 million, and Healthcare technology solutions contributing SGD10.46 million.
Market Cap: SGD858.03M
Boustead Singapore Limited demonstrates financial resilience with its short-term assets of SGD607.2 million exceeding both short- and long-term liabilities, highlighting strong liquidity. The company has reduced its debt-to-equity ratio significantly over five years, now holding more cash than total debt. Despite a low return on equity at 16.2%, Boustead’s earnings growth of 28.2% surpasses the industry average, indicating robust operational performance. However, the dividend yield of 3.24% is not well covered by free cash flows, suggesting potential sustainability concerns. Recent executive changes may impact strategic direction but could also bring fresh perspectives to management decisions.
SGX:F9D Financial Position Analysis as at Dec 2025
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Qinghai Spring Medicinal Resources Technology Co., Ltd. operates in the medicinal resources sector and has a market cap of approximately CN¥2.66 billion.
Operations: Qinghai Spring Medicinal Resources Technology Co., Ltd. has not reported any specific revenue segments.
Market Cap: CN¥2.66B
Qinghai Spring Medicinal Resources Technology shows financial stability with short-term assets of CN¥555.3 million surpassing its liabilities, and the company is debt-free. Despite being unprofitable, it has reduced losses significantly over five years and reported a net loss of CN¥2.83 million for the recent nine-month period, an improvement from the prior year’s larger loss. The management team and board are experienced, with tenures averaging over six years. With a cash runway exceeding three years based on current free cash flow trends, Qinghai Spring is positioned to sustain operations while seeking profitability improvements.
SHSE:600381 Financial Position Analysis as at Dec 2025
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SEHK:206 SGX:F9D and SHSE:600381.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
